Dr Klaus Rehe Kerrie Wilson Dr Simon Bomken Dr Daniel Williamson Professor Julie Irving et al. | Acute B lymphoblastic leukaemia-propagating cells are present at high frequency in diverse lymphoblast populations | 2013 |
|
Dr Klaus Rehe Kerrie Wilson Dr Simon Bomken Professor Olaf Heidenreich Professor Hermann Josef Vormoor et al. | In acute lymphoblastic leukaemia stemness is frequent and ubiquitous | 2011 |
|
Dr Klaus Rehe Kerrie Wilson Dr Simon Bomken Hesta McNeill Professor Julie Irving et al. | In Acute Lymphoblastic Leukaemia, Stemness Is Frequent and Ubiquitous | 2010 |
|
Dr Klaus Rehe Kerrie Wilson Dr Simon Bomken Hesta McNeill Professor Julie Irving et al. | In Acute Lymphoblastic Leukaemia, Sternness Is Frequent and Ubiquitous | 2010 |
|
Dr Klaus Rehe Kerrie Wilson Dr Simon Bomken Hesta McNeill Professor Julie Irving et al. | In acute lymphoblastic leukemia, stemness is frequent and ubiquitous | 2010 |
|
Dr Klaus Rehe Kerrie Wilson Hesta McNeill Professor Julie Irving Professor Hermann Josef Vormoor et al. | In standard and high risk acute lymphoblastic leukemias disease propagating cells are abundant and not confined to certain immunophenotypic fractions | 2010 |
|
Dr Klaus Rehe Kerrie Wilson Hesta McNeill Professor Hermann Josef Vormoor
| Disease Propagating Blasts in Standard and High Risk Acute Lymphoblastic Leukemia Are Frequent and of Diverse Immunophenotype | 2009 |
|
Dr Simon Bomken Kerrie Wilson Professor Julie Irving Professor Hermann Josef Vormoor
| In Childhood Acute Lymphoblastic Leukemia, Blasts at Different Stages of Immunophenotypic Maturation Have Stem Cell Properties | 2008 |
|
Kerrie Wilson Dr Klaus Rehe Dr Simon Bomken Marian Case Professor Julie Irving et al. | In Childhood ALL, Both Blasts with a CD20(-/Low) and a CD20(High) Immunophenotype, Have the Ability to Transfer the Leukemia Onto Immune-Deficient NOD/Scid Y-/- Mice | 2008 |
|
Kerrie Wilson Marian Case Lynne Minto Professor Simon Bailey Professor Hermann Josef Vormoor et al. | The CD34+ CD38Low CD19+ Candidate Leukemic Stem Cell Phenotype Revisited: Useful for Flow MRD Monitoring? | 2008 |
|
Dr David Jamieson Kerrie Wilson Dr Simon Pridgeon Dr Jane Margetts Professor Richard Edmondson et al. | NAD(P)H:quinone oxidoreductase 1 and NRH:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism | 2007 |
|